As Editor of Psychological Science in the Public Interest, Valerie Reyna commissioned Tom R. Tyler, Phillip Atiba Goff, and Robert J. MacCoun to write a report about the psychological science of policing in the U.S. Philip J. Cook was invited to write a commentary on the report.
The Nurse-Family Partnership Program received California Evidence-Based Clearinghouse for Child Welfare's (CEBC) highest rating, "Well-supported by Research Evidence" in the following areas: Home Visiting Programs for Child Well-Being; Home Visiting Programs for Prevention of Child Abuse and Neglect; Prevention of Child Abuse and Neglect (Primary) Programs; Teen Pregnancy Services.
Reducing the Risk Plus (RTR+) is an intervention for reducing sexual risk-taking in adolescents by Valerie Reyna and was rated as a best-evidence HIV behavioral intervention by the CDC. Best-evidence interventions are HIV behavioral interventions that have been rigorously evaluated and have been shown to have significant and positive evidence of efficacy (i.e., eliminate or reduce sex- or drug-risk behaviors, reduce the rate of new HIV/STD infections, or increase HIV-protective behaviors). These interventions are considered to be scientifically rigorous and provide the strongest evidence of efficacy. These interventions meet the PRS efficacy criteria for best evidence ILIs/GLIs/CPLs or efficacy criteria for best evidence CLIs.
Dr. Valerie Reyna is a member of National Academies' Committee on Pain Management and Regulatory Strategies To Address Prescription Opioid Abuse.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA’s development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Click to download a copy of the report.
This is an important report. Both untreated pain and the epidemic of opioid use are serious problems requiring urgent solutions. Somehow the balance must be found to both manage the increasing problem of pain in the aging US population, while regulating more effectively the diversion of prescription opioids into the broader population. This report represents the best thinking about how the balance might be made more effectively, while acknowledging the social determinants of opioid diversion and use in depressed communities.
- Professor Elaine Wethington, Professor, Department of Human Development, Department of Sociology, and Gerontology in Medicine, Weill Cornell Medicine